The granulocytopenic patient: Another consideration for antimicrobial prophylaxis

L. L. Otis, Geza T Terezhalmy

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Infection in the granulocytopenic patient is often life-threatening, and the frequency and severity of infection are increased regardless of the cause of leukocyte suppression. Trimethorprim-sulfamethoxazole plus nystatin is known to be effective in preventing colonization and infection by the primary pathogens responsible for the morbidity and mortality associated with granulocytopenia. When treating granulocytopenic patients, clinicians should use proper barrier techniques to minimize nosocomial colonization. When foci of oral infection are present or bacteremia is predictable, appropriate antibiotics should be prescribed.

Original languageEnglish (US)
Pages (from-to)125-129
Number of pages5
JournalOral Surgery, Oral Medicine, Oral Pathology
Volume60
Issue number1
DOIs
StatePublished - 1985

Fingerprint

Infection
Sulfamethoxazole
Nystatin
Agranulocytosis
Bacteremia
Leukocytes
Anti-Bacterial Agents
Morbidity
Mortality

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Dentistry(all)

Cite this

The granulocytopenic patient : Another consideration for antimicrobial prophylaxis. / Otis, L. L.; Terezhalmy, Geza T.

In: Oral Surgery, Oral Medicine, Oral Pathology, Vol. 60, No. 1, 1985, p. 125-129.

Research output: Contribution to journalArticle

@article{7d22681158be4c84ad5d381b7d6f318f,
title = "The granulocytopenic patient: Another consideration for antimicrobial prophylaxis",
abstract = "Infection in the granulocytopenic patient is often life-threatening, and the frequency and severity of infection are increased regardless of the cause of leukocyte suppression. Trimethorprim-sulfamethoxazole plus nystatin is known to be effective in preventing colonization and infection by the primary pathogens responsible for the morbidity and mortality associated with granulocytopenia. When treating granulocytopenic patients, clinicians should use proper barrier techniques to minimize nosocomial colonization. When foci of oral infection are present or bacteremia is predictable, appropriate antibiotics should be prescribed.",
author = "Otis, {L. L.} and Terezhalmy, {Geza T}",
year = "1985",
doi = "10.1016/0030-4220(85)90228-2",
language = "English (US)",
volume = "60",
pages = "125--129",
journal = "Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology",
issn = "2212-4403",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - The granulocytopenic patient

T2 - Another consideration for antimicrobial prophylaxis

AU - Otis, L. L.

AU - Terezhalmy, Geza T

PY - 1985

Y1 - 1985

N2 - Infection in the granulocytopenic patient is often life-threatening, and the frequency and severity of infection are increased regardless of the cause of leukocyte suppression. Trimethorprim-sulfamethoxazole plus nystatin is known to be effective in preventing colonization and infection by the primary pathogens responsible for the morbidity and mortality associated with granulocytopenia. When treating granulocytopenic patients, clinicians should use proper barrier techniques to minimize nosocomial colonization. When foci of oral infection are present or bacteremia is predictable, appropriate antibiotics should be prescribed.

AB - Infection in the granulocytopenic patient is often life-threatening, and the frequency and severity of infection are increased regardless of the cause of leukocyte suppression. Trimethorprim-sulfamethoxazole plus nystatin is known to be effective in preventing colonization and infection by the primary pathogens responsible for the morbidity and mortality associated with granulocytopenia. When treating granulocytopenic patients, clinicians should use proper barrier techniques to minimize nosocomial colonization. When foci of oral infection are present or bacteremia is predictable, appropriate antibiotics should be prescribed.

UR - http://www.scopus.com/inward/record.url?scp=0022263817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022263817&partnerID=8YFLogxK

U2 - 10.1016/0030-4220(85)90228-2

DO - 10.1016/0030-4220(85)90228-2

M3 - Article

C2 - 3162130

AN - SCOPUS:0022263817

VL - 60

SP - 125

EP - 129

JO - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

JF - Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

SN - 2212-4403

IS - 1

ER -